Clinical Trial Update: Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia. [Phase 4]

View source ↗

Summary

This update reports a Phase 4 clinical trial evaluating transdermal methylphenidate to reduce fall risk in people with dementia; the study was terminated and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia

Drugs mentioned

• Methylphenidate transdermal patch (methylphenidate)

Snippet

Sponsor: St. Louis University | Conditions: Dementia, Accidental Falls | Phase 4 | Status: TERMINATED | Results posted: 2016-08-19